Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 29 Jun 2023 09:44 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 26 Jun 2023 12:17 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 07:00 CEST |
CIRCIO HOLDING ASA | Circio: Første pasient med benmargskreft dosert med TG01 i studie på Oslo Universitetssykehus | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 22 Jun 2023 07:00 CEST |
CIRCIO HOLDING ASA | Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital | 20103010 Biotechnology | Non-regulatory press releases |
| 15 Jun 2023 07:00 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: June 2022 company update | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Jun 2023 21:51 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 Jun 2023 14:07 CEST |
CIRCIO HOLDING ASA | Flaggmelding | 20103010 Biotechnology | Flagging |
| 31 May 2023 07:00 CEST |
CIRCIO HOLDING ASA | Circio invites to a company update on Thursday 15 June 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 26 May 2023 10:02 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 25 May 2023 10:30 CEST |
TARGOVAX | Circio Holding ASA - New name registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2023 20:52 CEST |
TARGOVAX | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 May 2023 15:09 CEST |
TARGOVAX | Targovax ASA: Minutes from the Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 May 2023 15:30 CEST |
TARGOVAX | Circio: Link to recording and presentation from Company update 16[th] May 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 12 May 2023 07:00 CEST |
TARGOVAX | Circio invites to a company update on Tuesday 16 May 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 03 May 2023 12:15 CEST |
TARGOVAX | Targovax ASA - Correction of the proxy form attached to the notice of the Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 07:00 CEST |
TARGOVAX | Circio: circRNA poster to be presented at the ASGCT Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Apr 2023 08:58 CEST |
TARGOVAX | Targovax ASA - Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Apr 2023 20:32 CEST |
TARGOVAX | Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Apr 2023 20:32 CEST |
TARGOVAX | Targovax skifter navn til Circio og styrker satsingen på sirkulært RNA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 13 Apr 2023 23:36 CEST |
TARGOVAX | Targovax ASA: Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 13 Apr 2023 12:01 CEST |
TARGOVAX | Targovax ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 13 Apr 2023 09:54 CEST |
TARGOVAX | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Mar 2023 11:11 CEST |
TARGOVAX | Targovax ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Mar 2023 13:43 CET |
TARGOVAX | Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Mar 2023 08:28 CET |
TARGOVAX | Targovax: First patient dosed with TG01 in the USA | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Mar 2023 20:46 CET |
TARGOVAX | Targovax ASA - First Tranche of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2023 10:55 CET |
TARGOVAX | Targovax ASA: Minutes from the Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Mar 2023 20:42 CET |
TARGOVAX | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 07 Mar 2023 20:42 CET |
TARGOVAX | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Mar 2023 17:49 CET |
TARGOVAX | Targovax to prioritize resources on unlocking the potential of its circRNA platform | 20103010 Biotechnology | Inside information |
| 07 Mar 2023 17:49 CET |
TARGOVAX | Targovax prioriterer utvikling av sirkulær RNA plattform | 20103010 Biotechnology | Innsideinformasjon |
| 06 Mar 2023 17:44 CET |
TARGOVAX | Targovax ASA - Additional information prior to the Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Mar 2023 15:33 CET |
TARGOVAX | Targovax ASA: Registration of share capital increase following settlement of restricted stock units | 20103010 Biotechnology | Total number of voting rights and capital |
| 02 Mar 2023 13:25 CET |
TARGOVAX | Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 Mar 2023 13:15 CET |
TARGOVAX | Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Mar 2023 07:00 CET |
TARGOVAX | Targovax ASA - Additional information prior to the Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Feb 2023 11:50 CET |
TARGOVAX | Targovax invites to Q&A webcast regarding convertible bond financing | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Feb 2023 08:05 CET |
TARGOVAX | Disclosure in Targovax ASA | 20103010 Biotechnology | Major shareholding notifications |
| 16 Feb 2023 17:49 CET |
TARGOVAX | Targovax ASA - Notice of Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2023 07:00 CET |
TARGOVAX | Targovax ASA: Fourth quarter 2022 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 16 Feb 2023 06:55 CET |
TARGOVAX | Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform | 20103010 Biotechnology | Inside information |
| 16 Feb 2023 06:55 CET |
TARGOVAX | Targovax annonserer finansiering på inntil 300 millioner til utvikling av kreftmedisin og ny sirkulær RNA plattform | 20103010 Biotechnology | Innsideinformasjon |
| 08 Feb 2023 07:00 CET |
TARGOVAX | Targovax ASA: Invitation to Targovax's fourth quarter 2022 presentation, Thursday 16 February | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Dec 2022 07:00 CET |
TARGOVAX | Targovax announces that the TG01 study in multiple myeloma at Oslo University Hospital has received regulatory approvals to proceed | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Dec 2022 22:14 CET |
TARGOVAX | Targovax ASA issues options to employees | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Dec 2022 07:00 CET |
TARGOVAX | Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 15 Dec 2022 07:00 CET |
TARGOVAX | Targovax starter samarbeid med Agenus for å teste TG som behandling mot bukspyttkjertelkreft | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |